We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

The unregulated supply of AIDS drugs in the developing world could accelerate the development of drug-resistant HIV strains, according to an expert at the London School of Hygiene and Tropical Medicine, United Kingdom.

Better regulation of private-sector providers of drugs in poor nations is needed to ensure that patients use antiretroviral drugs correctly, thereby reducing the risk that a strain of drug-resistant HIV will develop.

Writing in this week's British Medical Journal, Ruairí Brugha says that because of the stigma associated with sexually transmitted diseases, most people with HIV in poor countries turn to private doctors and unlicensed drug vendors to obtain treatment.

But most of these private providers are not regulated. "Donors need to be more active in helping countries to fulfil their stewardship responsibilities in setting, prescribing and dispensing rules, [and] ensuring compliance," she says.

Link to BBC Online news story 'Warning over drug-resistant HIV'

Link to British Medical Journal article

© SciDev.Net 2003

Related topics